Insulet Corp
NASDAQ:PODD

Watchlist Manager
Insulet Corp Logo
Insulet Corp
NASDAQ:PODD
Watchlist
Price: 237.44 USD 0.78% Market Closed
Market Cap: 16.6B USD
Have any thoughts about
Insulet Corp?
Write Note

Insulet Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Insulet Corp
Revenue Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Insulet Corp
NASDAQ:PODD
Revenue
$1.9B
CAGR 3-Years
23%
CAGR 5-Years
23%
CAGR 10-Years
21%
Becton Dickinson and Co
NYSE:BDX
Revenue
$19.8B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
9%
Boston Scientific Corp
NYSE:BSX
Revenue
$15.9B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
8%
Stryker Corp
NYSE:SYK
Revenue
$22B
CAGR 3-Years
10%
CAGR 5-Years
9%
CAGR 10-Years
9%
Abbott Laboratories
NYSE:ABT
Revenue
$41.2B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Intuitive Surgical Inc
NASDAQ:ISRG
Revenue
$7.9B
CAGR 3-Years
13%
CAGR 5-Years
13%
CAGR 10-Years
14%

Insulet Corp
Revenue Breakdown

Breakdown by Geography
Insulet Corp

Total Revenue: 1.7B USD
100%
United States: 1.3B USD
75.8%
International: 410.1m USD
24.2%

Breakdown by Segments
Insulet Corp

Total Revenue: 1.7B USD
100%
Total Omnipod Products: 1.7B USD
97.9%
Drug Delivery: 36m USD
2.1%

See Also

What is Insulet Corp's Revenue?
Revenue
1.9B USD

Based on the financial report for Jun 30, 2024, Insulet Corp's Revenue amounts to 1.9B USD.

What is Insulet Corp's Revenue growth rate?
Revenue CAGR 10Y
21%

Over the last year, the Revenue growth was 28%. The average annual Revenue growth rates for Insulet Corp have been 23% over the past three years , 23% over the past five years , and 21% over the past ten years .

Back to Top